Evidence map›Paper›PMID 31391636›Full record

ArticleIndian journal of psychiatry2019

Medication adherence in first-episode psychosis and its association with psychopathology.

Vijaya Raghavan, Greeshma Mohan, Subhashini Gopal, Mangala Ramamurthy, Thara Rangaswamy

Open access · diamondAbstract read
In one paragraph

Article in Indian journal of psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. A Multicentre, Randomised, Controlled Trial of a Combined Clinical Treatment for First-Episode Psychosis.International journal of environmental research and public health · 2021
    Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Dynamics between insight and medication adherence in first-episode psychosis: Study of 3-year trajectories.European psychiatry : the journal of the Association of European Psychiatrists · 2022
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Vijaya RaghavanConsultant Psychiatrist, Schizophrenia Research Foundation, Chennai, Tamil Nadu, India.
Greeshma MohanPsychologist, Schizophrenia Research Foundation, Chennai, Tamil Nadu, India.
Subhashini GopalPsychologist, Schizophrenia Research Foundation, Chennai, Tamil Nadu, India.
Mangala RamamurthyConsultant Psychiatrist, Schizophrenia Research Foundation, Chennai, Tamil Nadu, India.
Thara RangaswamyConsultant Psychiatrist, Schizophrenia Research Foundation, Chennai, Tamil Nadu, India.
Schizophrenia Research Foundation · IN

Funding

INDO - US TRAINING PROGRAM IN BEHAVIORAL HEALTH ACROSS THE LIFESPAND43TW009120 · FIC · UNIVERSITY OF FLORIDA · PI COTTLER, LINDA B. · 2011 to 2015
$1.1M
FIC NIH HHS D43 TW009120
6 · The paper itself

Abstract

backgroundThe purpose of the study was to follow-up the individuals with first-episode psychosis (FEP) for a period of 1 year to assess their medication adherence rates and to identify the association between medication adherence and psychopathology. MATERIALS AND

methodsIn a 1 year longitudinal study, 59 individuals with FEP were assessed for their sociodemographic profile and medication adherence at 1 month and 12-month follow-up period using a semi-structured per forma. Positive and negative symptoms were assessed by positive and negative syndrome scale (PANSS) while the functioning by global assessment of functioning (GAF) scale.

resultsNearly 85% of the individuals were adherent with medications during the 1-month follow-up period, 32.2% were poorly adherent at the end of 12 months. Among various factors examined for association with medication adherence, positive and negative symptoms, and global functioning of the individuals at the end of 12 months were found to significant associated with poor medication adherence.

conclusionThere is a high rate of medication nonadherence in individuals with FEP at 12-month follow-up, and factors affecting nonadherence should be addressed specifically to improve medication adherence in these individuals.

Indexed as

First-episode psychosisfollow-upmedication adherencepsychopathology

Identifiers

PMID31391636
PMCPMC6657546
OpenAlexW2960332552

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.